Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2024HeliyonOpen Access

Safety and efficacy of RCP recombinant spike protein covid-19 vaccine compared to Sinopharm BBIBP: A phase III, non-inferiority trial

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMasoud Solaymani–DodaranSKSaeed KalantariSBSeyed Reza Banihashemi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Solaymani–Dodaran et al. (2024) studied this question.

synapsesocial.com/papers/68e7632bb6db6435876d8b51https://doi.org/10.1016/j.heliyon.2024.e27370
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine2020 · 10,918 citations
  2. 2Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes2020 · 805 citations
  3. 3Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine2020 · 15,754 citations
  4. 4Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models2022 · 50 citations
  5. 5Vaccination to reduce severe COVID-19 and mortality in COVID-19 patients: a systematic review and meta-analysis.2022 · 93 citations